Trade Morphosys AG - MOR shares price

Open on web platform

Market info

Min traded quantity:: 1
Full name:: Morphosys AG
Currency:: EUR
Margin:: 5%
Stock exchange:: Germany
Long position overnight fee: -0.0137%
Short position overnight fee: -0.0168%

Trading hours (UTC)

Mon - Fri:: 07:02 - 15:30

MOR

Based in Martinsried, Germany, MorphoSys (MOR) is a pharmaceutical company committed to antibody development. All antibodies, created by MorphoSys, are composed of 100% protein. The company’s most advanced technology, HuCAL, is designed to approach drug discovery in a smart new way. In total, MorphoSys has developed a portfolio of over 100 human antibodies built with such compounds as guselkumab, anetumab ravtansine, gantenerumab. MorphoSys stock is quoted at Frankfurt Stock Exchange. The company is featured in the TecDAX index.
White Paper Declaration

You might be interested in

MIC

Macquarie Infrastructure Corporation

Sell Buy

28.94

MMB

Lagardere

Sell Buy

13.515

MKC

McCormick

Sell Buy

175.39

MLM

Martin Marietta Materials

Sell Buy

204.94

Crypto as collateral

Trade the global financial markets using Bitcoin or Ethereum.

Security as priority

Authorised by the High Technology Park of Belarus, the European blockchain regulator, the safety of your holdings is guaranteed.

Technical indicators

Keep an eye on your positions with over 75 advanced charts, price analysis and price alerts.

Control your capital

Use stop-loss and take-profit orders to keep what you earn.

Use the world’s first regulated tokenised assets exchange to build a diverse investment portfolio with your crypto holdings. Make your deposits in Bitcoin or Ethereum to trade global financial instruments with competitive leverage and tight spreads. Currency.com keeps your holdings secure and accessible at a glance.